The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Calpol Six Plus Fastmelts 250 mg Paracetamol orodispersible tablets

Johnson & Johnson (Ireland) LimitedPA0330/017/005

Main Information

Trade NameCalpol Six Plus Fastmelts 250 mg Paracetamol orodispersible tablets
Active SubstancesParacetamol
Dosage FormOrodispersible tablet
Licence HolderJohnson & Johnson (Ireland) Limited
Licence NumberPA0330/017/005

Group Information

ATC CodeN02BE Anilides
N02BE01 paracetamol


License statusAuthorised
Licence Issued23/02/2001
Legal statusProduct not subject to medical prescription
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceNone
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back